← Leaderboards
Joseph A Murray
Mayo Clinic Coll Of Medicine, Rochester
$9,616,112
Attributed
$18,934,942
Total exposure
9
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,934,942 · 9
By mechanism
RC2$9,512,977 · 1
R01$5,035,192 · 2
U44$2,496,459 · 1
R33$1,467,352 · 1
R56$394,250 · 1
M01$28,712 · 3
Top collaborators
- Jack A. Syage7 shared
- Luis Bruno Barreiro4 shared
- Rustem F Ismagilov4 shared
- Bana Jabri4 shared
- Chaitan Khosla1 shared
- Thaddeus S Stappenbeck1 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Ronald C Petersen$104,627,909
- Chella S David$12,457,836
- Michael L Camilleri$18,731,842
- John C Burnett$28,252,772
Others in their field
Top investigators on “Celiac Disease”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Bana Jabri · University Of Chicago$19,892,166
- Marian J. Rewers · University Of Colorado Denver$18,886,552
- Chaitan Khosla · Stanford University$11,313,416
- Ake Lernmark · University Of Washington$10,750,847
- Alessio Fasano · University Of Maryland Baltimore$8,450,994
Research focus
Celiac DiseaseGlutenClinical ResearchDietBaseAffectDiagnosisSymptomsMucous MembraneLifeDiagnosticInflammatoryIntestinesSamplingSmall IntestinesHuman SubjectFundingProgramsEpidemiologyComorbidityAdultDigestive System DisordersFamily MemberFollow-Up
Grant awards (36)
Tissue destruction and healing in Celiac Disease$2,394,224
RC2 · FY2025 · DK
Tissue destruction and healing in Celiac Disease$2,298,454
RC2 · FY2024 · DK
Tissue destruction and healing in Celiac Disease$2,394,001
RC2 · FY2023 · DK
Tissue destruction and healing in Celiac Disease$2,426,298
RC2 · FY2022 · DK
A Clinical Study of Latiglutenase as a Treatment for Symptom Reduction for Celiac Disease$200,524
U44 · FY2022 · AI
A Clinical Study of Latiglutenase as a Treatment for Symptom Reduction for Celiac Disease$998,618
U44 · FY2021 · AI
A Clinical Study of Latiglutenase as a Treatment for Symptom Reduction for Celiac Disease$998,228
U44 · FY2020 · AI
Latiglutenase as a Treatment for Celiac Disease$259,102
R33 · FY2020 · AT
A Clinical Study of Latiglutenase as a Treatment for Symptom Reduction for Celiac Disease$299,089
U44 · FY2019 · AI
Latiglutenase as a Treatment for Celiac Disease$615,254
R33 · FY2018 · AT
Latiglutenase as a Treatment for Celiac Disease$592,996
R33 · FY2017 · AT
A HLA Mouse Model for Gluten Sensitivity and Enteropathy$394,250
R56 · FY2010 · DK · contact PI
Epidemiology of Celiac Disease: A Population Based Study$360,062
R01 · FY2010 · DK · contact PI
Epidemiology of Celiac Disease: A Population Based Study$98,782
R01 · FY2010 · DK · contact PI
Epidemiology of Celiac Disease: A Population Based Study$385,159
R01 · FY2009 · DK · contact PI
A HLA Mouse Model for Gluten Sensitivity and Enteropathy$281,668
R01 · FY2009 · DK · contact PI
Epidemiology of Celiac Disease: A Population Based Study$19,114
R01 · FY2009 · DK · contact PI
Epidemiology of Celiac Disease: A Population Based Study$373,693
R01 · FY2008 · DK · contact PI
A HLA Mouse Model for Gluten Sensitivity and Enteropathy$281,668
R01 · FY2008 · DK · contact PI
Epidemiology of Celiac Disease: A Population Based Study$373,764
R01 · FY2007 · DK · contact PI
A HLA Mouse Model for Gluten Sensitivity and Enteropathy$287,416
R01 · FY2007 · DK · contact PI
Epidemiology of Celiac Disease: A Population Based Study$514,116
R01 · FY2006 · DK · contact PI
A HLA Mouse Model for Gluten Sensitivity and Enteropathy$296,000
R01 · FY2006 · DK · contact PI
EPIDEMIOLOGY OF CELIAC DISEASE: A POPULATION-BASED STUDY$9,477
M01 · FY2005 · RR
EPIDEMIOLOGY OF CELIAC DISEASE--A POPULATION BASED STUDY$352,750
R01 · FY2004 · DK
Epidemiology of Celiac Disease: A Population-Based Study$19,235
M01 · FY2004 · RR
EPIDEMIOLOGY OF CELIAC DISEASE--A POPULATION BASED STUDY$352,750
R01 · FY2003 · DK
EPIDEMIOLOGY OF CELIAC DISEASE--A POPULATION BASED STUDY$352,750
R01 · FY2002 · DK
13 C SPIRULINA BREATH TEST TO MEASURE GASTRIC EMPTYING$0
M01 · FY2002 · RR
ESOPHAGEAL IMPEDENCE MEASUREMENT AND DETECTION OF GASTROESOPHAGEAL REFLUX$0
M01 · FY2002 · RR
EPIDEMIOLOGY OF CELIAC DISEASE--A POPULATION BASED STUDY$352,750
R01 · FY2001 · DK
13 C SPIRULINA BREATH TEST TO MEASURE GASTRIC EMPTYING$0
M01 · FY2001 · RR
ESOPHAGEAL IMPEDENCE MEASUREMENT AND DETECTION OF GASTROESOPHAGEAL REFLUX$0
M01 · FY2001 · RR
EPIDEMIOLOGY OF CELIAC DISEASE--A POPULATION BASED STUDY$352,750
R01 · FY2000 · DK
ESOPHAGEAL IMPEDENCE MEASUREMENT AND DETECTION OF GASTROESOPHAGEAL REFLUX$0
M01 · FY2000 · RR
13 C SPIRULINA BREATH TEST TO MEASURE GASTRIC EMPTYING$0
M01 · FY2000 · RR